RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
R Kalkan, M Altarda, O Tosun
Do we use methylation of NFATC1 and FOS genes as a biomarker for postmenopausal osteoporosis?
R Kalkan, O Tosun
Pros and cons for fluorescent in situ hybridization, karyotyping and next generation sequencing for diagnosis and follow-up of multiple myeloma
E Ikbal Atli, H Gurkan, H Onur Kirkizlar, E Atli, S Demir, S Yalcintepe, R Kalkan, AM Demir
Determination of the Relationship Between DNA Methylation Status of KLOTHO and ARNTL Genes With Hypertension
M Osum, O Tosun, H Birtan, R Kalkan
G Protein-Coupled Receptor 35 Holds Potential as a Beacon of Hope for Treating Chondrosarcoma
A Tuncal, R Kalkan